Sep 30, 2019

Gilead Sciences Q3 2019 Earnings Report

Total Revenue
$5.6B
Previous year: $5.6B
+0.1%
EPS
$1.75
Previous year: $1.84
-4.9%
Product gross margin
81.2%
Gross Profit
$4.57B
Previous year: $4.51B
+1.3%
Cash and Equivalents
$9.47B
Previous year: $14.6B
-35.0%
Free Cash Flow
$2.7B
Previous year: $2.05B
+32.0%
Total Assets
$59.1B
Previous year: $64.3B
-8.0%

Gilead Sciences

Gilead Sciences